Violetta Serra

46PUBLICATIONS
461CO-AUTHORS
Molecular targetsCancer geneticsInnate immunityHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jul 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|Mar 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Stefan J Hutten, Xue Chao, Madelon Badoux

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Jan 12, 2026
Interpretable inflammation landscape of circulating immune cells.

Laura Jiménez-Gracia, Davide Maspero, Sergio Aguilar-Fernández

|Mar 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer.

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino

|Jan 09, 2025
RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial.

Guillermo Villacampa, Alba Llop-Guevara, Natalie Filmann

Pageof 8

Frequent Collaborators

10 joint publications

Alba Llop-Guevara

9 joint publications

Joaquín Arribas

8 joint publications

Paolo Nuciforo

7 joint publications

Cristina Saura